\u201cThere is little, or no evidence base for many of the conditions for which it is being prescribed, such as anxiety, insomnia, or depression,\u201d McMullen said.<\/p>\n
In its submission to an Australian Government inquiry into the industry, the AMA called for \u201ccomprehensive reform\u201d of the way medical cannabis was bought and sold.<\/p>\n
Members working in emergency departments were calling for more resources to deal with growing numbers of patients with cases related to excessive intake of cannabis, including psychosis, the association said.<\/p>\n
\u201cAlarmingly, doctors are seeing medicinal cannabis use in people who have pre-existing psychotic conditions.\u201d<\/p>\n
The AMA warned that telehealth models \u2013 in which patients can be issued prescriptions online without an in-person doctor visit \u2013 were being \u201cexploited as commercial pathways for unapproved products\u201d.<\/p>\n
This year, newspaper the Age revealed that one doctor working for medical cannabis giant Montu had issued 72,000 prescriptions to 10,000 patients in just two years.<\/p>\n
In some instances, the newspaper reported, consultations with patients were scheduled to last no longer than 10 minutes.<\/p>\n
The global medical cannabis market is expected to grow to over US$65 billion by 2030, according to consulting firm Grand View Research.<\/p>\n
-Agence France-Presse<\/p>\n","protected":false},"excerpt":{"rendered":"\u201cThere is little, or no evidence base for many of the conditions for which it is being prescribed,…\n","protected":false},"author":3,"featured_media":301663,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[9858,50113,153284,1749,153287,14206,153283,153285,210,3195,46405,1083,1060,130590,1539,127336,59809,52210,26198,3229,20644,67,132,153286,68,153282,153288,24827,1917],"class_list":["post-301662","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-association","tag-australian","tag-australias","tag-cannabis","tag-countrys","tag-doctors","tag-excessive","tag-excessively","tag-health","tag-industry","tag-little","tag-medical","tag-medication","tag-needs","tag-of","tag-oversight","tag-pharmacists","tag-prescribing","tag-prescriptions","tag-regulation","tag-today","tag-united-states","tag-unitedstates","tag-urgent","tag-us","tag-warn","tag-warned","tag-weed","tag-with"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115370538183449501","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/301662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=301662"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/301662\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/301663"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=301662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=301662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=301662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}